Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 73 (2023): Issue 4 (December 2023)
Open Access
Size exclusion chromatography as green support for forced degradation study of adalimumab
Jelena Kovačić
Jelena Kovačić
,
Daniela Amidžić Klarić
Daniela Amidžić Klarić
,
Nikša Turk
Nikša Turk
and
Ana Mornar
Ana Mornar
| Dec 26, 2023
Acta Pharmaceutica
Volume 73 (2023): Issue 4 (December 2023)
Special Issue
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 26, 2023
Page range:
709 - 721
Accepted:
Nov 24, 2023
DOI:
https://doi.org/10.2478/acph-2023-0044
Keywords
inflammatory bowel disease
,
biopharmaceuticals
,
adalimumab
,
size exclusion chromatography
,
forced degradation study
© 2023 Jelena Kovačić et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.